ORIGINAL ARTICLE
Brain Tumor Res Treat 2017;5(1):16-23 / pISSN 2288-2405 / eISSN 2288-2413 https://doi.org/10.14791/btrt.2017.5.1.16
An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013 Yun-Sik Dho1*, Kyu-Won Jung2*, Johyun Ha2, Youngbeom Seo3, Chul-Kee Park1, Young-Joo Won2, Heon Yoo4 Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea Cancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea 3 Department of Neurosurgery, Yeungnam University Hospital, Daegu, Korea 4 Neuro-Oncology Clinic, National Cancer Center, Goyang, Korea 1 2
Received March 3, 2017 Revised April 19, 2017 Accepted April 19, 2017 Correspondence Heon Yoo Neuro-Oncology Clinic, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea Tel: +82-31-920-2435 Fax: +82-31-920-1520 E-mail: [email protected] Correspondence Young-Joo Won Cancer Registration and Statistic Branch, National Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea Tel: +82-31-920-2015 Fax: +82-31-920-2179 E-mail: [email protected]
Background This report aims to provide accurate nationwide epidemiologic data on primary brain and central nervous system (CNS) tumors in the Republic of Korea. We updated the data by analyzing primary brain and CNS tumors diagnosed in 2013 using the data from the national cancer incidence database. Data on primary brain and CNS tumors diagnosed in 2013 were collected from the Methods Korean Central Cancer Registry. Crude and age-standardized rates were calculated in terms of gender, age, and histological type. A total of 11,827 patients were diagnosed with primary brain and CNS tumors in Results 2013. Brain and CNS tumors occurred in females more often than in males (female:male, 1.70:1). The most common tumor was meningioma (37.3%). Pituitary tumors (18.0%), gliomas (12.7%), and nerve sheath tumors (12.3%) followed in incidence. Glioblastomas accounted for 41.8% of all gliomas. In children (
Brain Tumor Res Treat 2017;5(1):16-23 / pISSN 2288-2405 / eISSN 2288-2413 https://doi.org/10.14791/btrt.2017.5.1.16
An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013 Yun-Sik Dho1*, Kyu-Won Jung2*, Johyun Ha2, Youngbeom Seo3, Chul-Kee Park1, Young-Joo Won2, Heon Yoo4 Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea Cancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea 3 Department of Neurosurgery, Yeungnam University Hospital, Daegu, Korea 4 Neuro-Oncology Clinic, National Cancer Center, Goyang, Korea 1 2
Received March 3, 2017 Revised April 19, 2017 Accepted April 19, 2017 Correspondence Heon Yoo Neuro-Oncology Clinic, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea Tel: +82-31-920-2435 Fax: +82-31-920-1520 E-mail: [email protected] Correspondence Young-Joo Won Cancer Registration and Statistic Branch, National Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea Tel: +82-31-920-2015 Fax: +82-31-920-2179 E-mail: [email protected]
Background This report aims to provide accurate nationwide epidemiologic data on primary brain and central nervous system (CNS) tumors in the Republic of Korea. We updated the data by analyzing primary brain and CNS tumors diagnosed in 2013 using the data from the national cancer incidence database. Data on primary brain and CNS tumors diagnosed in 2013 were collected from the Methods Korean Central Cancer Registry. Crude and age-standardized rates were calculated in terms of gender, age, and histological type. A total of 11,827 patients were diagnosed with primary brain and CNS tumors in Results 2013. Brain and CNS tumors occurred in females more often than in males (female:male, 1.70:1). The most common tumor was meningioma (37.3%). Pituitary tumors (18.0%), gliomas (12.7%), and nerve sheath tumors (12.3%) followed in incidence. Glioblastomas accounted for 41.8% of all gliomas. In children (
